Cargando…
Potential Protective Effects of Equol (Soy Isoflavone Metabolite) on Coronary Heart Diseases—From Molecular Mechanisms to Studies in Humans
Equol, a soy isoflavone-derived metabolite of the gut microbiome, may be the key cardioprotective component of soy isoflavones. Systematic reviews have reported that soy isoflavones have no to very small effects on traditional cardiovascular disease risk factors. However, the potential mechanistic m...
Autores principales: | Zhang, Xiao, Veliky, Cole V., Birru, Rahel L., Barinas-Mitchell, Emma, Magnani, Jared W., Sekikawa, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622975/ https://www.ncbi.nlm.nih.gov/pubmed/34835997 http://dx.doi.org/10.3390/nu13113739 |
Ejemplares similares
-
Potential Protective Mechanisms of S-equol, a Metabolite of Soy Isoflavone by the Gut Microbiome, on Cognitive Decline and Dementia
por: Sekikawa, Akira, et al.
Publicado: (2022) -
Effect of S-equol and Soy Isoflavones on Heart and Brain
por: Sekikawa, Akira, et al.
Publicado: (2019) -
Pharmacokinetics
of Equol, a Soy Isoflavone Metabolite,
Changes with the Form of Equol (Dietary versus Intestinal Production)
in Ovariectomized Rats
por: Legette, LeeCole L., et al.
Publicado: (2014) -
The impact of equol-producing status in modifying the effect of soya isoflavones on risk factors for CHD: a systematic review of randomised controlled trials
por: Birru, Rahel L., et al.
Publicado: (2016) -
Cross-sectional association of equol producing status with aortic calcification in Japanese men aged 40–79 years
por: Zhang, Xiao, et al.
Publicado: (2022)